CIVI BIOPHARMA
CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular and metabolic therapies that have meaningful value to patients. The company has multiple assets in various stages of development including Intravenous Iloprost in Phase 3 trials for treatment of Systemic Sclerosis.
CIVI BIOPHARMA
Social Links:
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
2016-01-01
Address:
Chevy Chase, Maryland, United States
Country:
United States
Website Url:
http://www.civibio.com
Total Employee:
11+
Status:
Active
Contact:
301-968-2390
Email Addresses:
[email protected]
Total Funding:
89 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Bracket
Bracket bring together best-in-class science, technology & service to drive superior clinical outcome results for pharmaceutical companies.
Cellular Bioengineering
Cellular Bioengineering is an accelerator of disruptive technologies with biomedical and biodefense applications.
GenZum Life Sciences
Genzum Life Sciences is a globally integrated Generic Pharmaceutical Product Development and Out-licensing company, based in Los Angeles
Ikan Biotech
Ikan Biotech is a CRO specialized in developing new enzybiotics combining with preclinical services using zebrafish.
Nuovo Biologics
Nuovo Biologics is engaged in the research and development of animal health products.
SIGNATOPE
SIGNATOPE develops the next generation of protein biomarker assays using a special type of immunoaffinity based mass spectrometry assays.
Spitfire Pharma
Spitfire Pharma offers drug development and research services that improve the pharmaceutical properties of peptide drugs.
Transparency Life Sciences
Transparency Life Sciences is a world's first drug development services company based on open innovation.
Zenith Epigenetics
Zenith Epigenetics is a research and development biotechnology company focused on new and innovative drugs.
Current Employees Featured
Founder
Investors List
Boxer Capital
Boxer Capital investment in Venture Round - CiVi Biopharma
Roche Venture Fund
Roche Venture Fund investment in Venture Round - CiVi Biopharma
Tang Capital Management
Tang Capital Management investment in Venture Round - CiVi Biopharma
RA Capital Management
RA Capital Management investment in Venture Round - CiVi Biopharma
Boxer Capital
Boxer Capital investment in Series A - CiVi Biopharma
Official Site Inspections
http://www.civibio.com Semrush global rank: 5.68 M Semrush visits lastest month: 1.48 K
- Host name: 71.29.184.35.bc.googleusercontent.com
- IP address: 35.184.29.71
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "CiVi Biopharma"
About - CiVi Biopharma
About CiVi Biopharma Holding Corp. is a clinical-stage research and development biotechnology company whose mission is to create novel cardiovascular and metabolic therapies that have …See details»
Home - CiVi Biopharma
Oct 1, 2020 CiVi 030 is an intravenous formulation of iloprost, a potent vasodilator and platelet inhibitor with anti-inflammatory and anti-fibrotic effects being developed for the treatment of severe frostbite.See details»
Management Team - CiVi Biopharma
Prior to joining CiVi Biopharma, Mr. Jacobovitz was the Chief Executive Officer of the American College of Cardiology. In this role, he led the 52,000+ member organization in its mission to …See details»
CiVi Biopharma - Crunchbase Company Profile
CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.See details»
CiVi Biopharma, Inc. - LinkedIn
CiVi Biopharma Inc. is a US-based, privately-held biopharmaceutical company, founded in 2016. The Company's research and development activities are focused on creating novel therapies for ...See details»
CiVi Biopharma 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for CiVi Biopharma. Use the PitchBook Platform to explore the full profile.See details»
CiVi Biopharma - Org Chart, Teams, Culture & Jobs
View CiVi Biopharma's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
CiVi Biopharma - 2025 Company Profile - Tracxn
Mar 10, 2025 CiVi Biopharma - Developer of therapeutics for cardiovascular diseases. Raised a total funding of $116M over 3 rounds from 2 investors.See details»
Civi Biopharma, Inc. Company Profile | Chevy Chase, MD
Find company research, competitor information, contact details & financial data for Civi Biopharma, Inc. of Chevy Chase, MD. Get the latest business insights from Dun & Bradstreet.See details»
CiVi Biopharma, Inc. - Company Profile & Staff Directory
CiVi Biopharma, Inc. is a Biotechnology company located in 5425 Wisconsin Ave, 6th Floor, Chevy Chase, Maryland 20815, US with 13 employees. Access CiVi Biopharma, Inc.'s email …See details»
CiVi Biopharma, Inc. - Drug pipelines, Patents, Clinical trials
Explore CiVi Biopharma, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 3 news, and 1 literature, Disease Domain:Endocrinology ...See details»
CiVi Biopharma - Overview, News & Similar companies - ZoomInfo
Oct 1, 2020 View CiVi Biopharma (www.civibio.com) location in Maryland, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
CiVi Biopharma, Inc. Information - RocketReach
CiVi Biopharma, Inc. is a Clinical Trials, Biotechnology Research, and Manufacturing General company located in Chevy Chase, Maryland with $2 million in revenue and 10 employees. …See details»
CiVi Biopharma - Craft
CiVi Biopharma is a clinical-stage research and development biotechnology company. It focuses on creating therapies for cardiovascular, metabolic, and related diseases. CiVi Biopharma's …See details»
Board of Directors - CiVi Biopharma
Prior to joining CiVi Biopharma, Mr. Jacobovitz was the Chief Executive Officer of the American College of Cardiology. In this role, he led the 52,000+ member organization in its mission to …See details»
CiVi Biopharma, Inc. | CipherBio
Explore CiVi Biopharma, Inc.'s investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
CiVi Website Investor Deck
The company obtained the industry, market and competitive position data used throughout this presentation from its own internal estimates and research, as well as from industry and …See details»
CiVi Biopharma Resumes AURORA Phase 3 Clinical Trial of
Oct 1, 2020 CiVi Biopharma has been supported by venture financing from Boxer Capital of the Tavistock Group and Roche Ventures, among others. Contact: Jared Jacobovitz Director of …See details»
Pipeline - CiVi Biopharma
Pipeline Advancing a robust clinical development pipeline with a mix of late, mid and early-stage programsSee details»
CiVi 008 - CiVi Biopharma
CiVi 008 CiVi 008 is a third-generation proprotein convertase subtilisin/kexin type 9 (PCSK9) antisense molecule being developed as an oral treatment for hypercholesterolemia and the …See details»